miércoles, 22 de julio de 2009

Pancreatic Cancer Patients Could Live Longer With New Drug

No cancer is good, but pancreatic cancer is one of the worst kinds you can get.

The 5-year survival rate is about 5%. So it's major news that this new drug, given in combination with the standard pancreatic cancer drug, almost doubled the life expectancy of those who received it.

Source:
http://www.sciencedaily.com/releases/2009/07/090720134512.htm